-
The most appropriate time to intervene in asymptomatic patients with chronic severe aortic regurgitation is controversial. Since brain natriuretic peptide (BNP) is released by the heart in response to increased wall stress, it has been proposed as a biomarker of the time to intervene in chronic valvular regurgitation patients.
-
Clopidogrel therapy is indicated for many patients with cardiovascular disease, particularly those who have had percutaneous coronary intervention (PCI).
-
Since there is a lack of prospective data on the frequency of which constrictive pericarditis (CP) develops after acute pericarditis (AP), this group of investigators from Torino, Italy, conducted such a study.
-
The management of chronic heart failure patients would benefit from an accurate noninvasive way to estimate left atrial pressure (LAP).
-
-
Patients who have had percutaneous coronary intervention (PCI) with either bare metal stents (BMS) or drug-eluting stents (DES) require dual antiplatelet therapy until the stent struts are endothelialized.
-
This paper describes the mortality and economic costs of infections associated with pacemakers and implantable defibrillators (ICDs) in Medicare recipients.
-
Medication poisonings in children; rosuvastatin vs atorvastatin for atherosclerosis; saw palmetto for prostate symptoms; using atypical antipsychotics for off-label indications in adults; and FDA actions.
-
In this study, Siklody and her colleagues from three large and experienced atrial fibrillation (AF) ablation centers performed cerebral magnetic resonance imaging before and after AF ablation using three different catheter technologies.
-
In severe symptomatic aortic stenosis (AS), surgical AVR improves mortality, but there is no medical therapy proven to slow progression of the valvular stenosis.